EBIT at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s EBIT?
- Krystal Biotech, Inc. (KRYS) reported EBIT of $53.69M in Q1 2026.
- How has Krystal Biotech, Inc.'s EBIT changed year-over-year?
- Krystal Biotech, Inc.'s EBIT increased by 48.1% year-over-year, from $36.25M to $53.69M.
- What is the long-term trend for Krystal Biotech, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s EBIT has grown at a 24.0% compound annual growth rate (CAGR), from -$68.27M to $161.2M.
- What does EBIT mean?
- Profit before interest and taxes — the business's core earning power.
- How do you interpret EBIT?
- Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
- How does EBIT compare across companies?
- Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.